Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (55)
  • 2025 (27)

Subject

  • Drug Trafficking (1305)
  • Synthetic drugs (450)
  • Arrests/Convictions - Major (368)
  • Guns/Weapons (326)
  • Fake Pills (273)
  • OCDETF/Task Force (191)
  • Seizures (Drugs/Property) (191)
  • Guilty Plea (181)
  • Fentanyl Free America (142)
  • Fentanyl Awareness (136)
  • Prescription Drugs (107)
  • Counterfeit Pills (104)
  • Task Forces/Task Force Officers (98)
  • Diversion Division (92)
  • Major Law Enforcement Operation (91)
  • Money Laundering (74)
  • Outreach/Drug Prevention (69)
  • Overdose (69)
  • Take Back Day (63)
  • One Pill Can Kill (55)
  • Gangs (53)
  • HIDTA (32)
  • Other (29)
  • Cartel (28)
  • Press Conferences (23)
  • Extraditions (22)
  • Narcoterrorism (22)
  • Prevention/Education - DEA websites GSAD, JTT etc (20)
  • Terrorism (11)
  • International/Foreign Operations (10)
  • Public and Media Affairs - also see Congressional Affairs (10)
  • Dark Web- Internet Trafficking (7)
  • Critical Incident (5)
  • Asset Forfeiture (4)
  • Intelligence Division - Intelligence Products (4)
  • Intergovernmental Affairs (2)
  • Museum and Visitors Center (2)
  • Red Ribbon (2)
  • Forensics: Quality Management System Documents (1)
  • Pharmaceuticals/Pharmacists/Physicians (53)
  • Campaigns (29)

Drug Name

  • Fentanyl (15)
  • Oxycodone (6)
  • Hydromorphone (4)
  • Cocaine (3)
  • Methamphetamine (3)
  • Benzodiazepines (1)
  • Heroin (1)
  • Marijuana (Cannabis) (1)
  • Morphine (1)
  • Opioids (1)

Field Division

  • Atlanta (4)
  • Caribe (2)
  • Chicago (1)
  • Dallas (2)
  • Detroit (1)
  • El Paso (6)
  • Los Angeles (1)
  • Louisville (10)
  • Miami (4)
  • New England (1)
  • New Jersey (3)
  • New Orleans (1)
  • New York (6)
  • Omaha (4)
  • Phoenix (3)
  • Rocky Mountain (3)
  • San Diego (1)
  • San Francisco (10)
  • Seattle (3)
  • Sede (5)
  • St. Louis (8)
  • Tampa (1)
  • Washington, DC (2)
Clear All Results
View Archived Press Releases
82 Results - Showing 61 to 70
PRESS RELEASE

Southern New Mexico Medical Spa Operator Settles Allegations of Controlled-Substance Recordkeeping Violations

Note: View the Settlement Agreement ALBUQUERQUE – The United States has reached a civil settlement with Luis Carlos Cordova, operator of Limitless Aesthetics and Healthcare in Santa Teresa, New Mexico, to resolve allegations that he failed to meet federal controlled-substance recordkeeping requirements under the Controlled Substances Act. According to the...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

DETROIT – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment to...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

DALLAS – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment to...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

ARIZONA – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment to...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

ST. LOUIS – The U.S. Drug Enforcement Administration (DEA) is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. Through intensified enforcement operations and...
PRESS RELEASE

DEA Launches Fentanyl Free America Initiative to Combat the Synthetic Drug Crisis

LOUISVILLE, Ky. – The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America; a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA's unwavering commitment...
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

SAN FRANCISCO – United States Drug Enforcement Administration (“DEA”) San Francisco Division Special Agent in Charge Bob Beris, DEA New York Division Special Agent in Charge Frank Tarentino, along with our law enforcement partners Homeland Security Investigations (“HSI”) , U.S. Department of Health and Human Services – Office of Inspector...
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

NEW YORK – United States Drug Enforcement Administration (“DEA”) New York Division Special Agent in Charge Frank Tarentino, DEA San Francisco Division Special Agent in Charge Robert Beris, along with our law enforcement partners Homeland Security Investigations (“HSI”) New York , U.S. Department of Health and Human Services – Office...
PRESS RELEASE

DEA Hosts the 29th National Prescription Drug Take Back Day on Saturday, October 25th

SAN FRANCISCO – The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription...
PRESS RELEASE

Clay County Pharmacy Investigation and Prosecution Ends in Guilty Pleas

NASHVILLE – Thomas K. Weir, 65, majority owner of Oakley Pharmacy d/b/a Dale Hollow Pharmacy and Clay County Xpress Pharmacy (“Xpress Pharmacy”); William L. Donaldson, 65, former owner and pharmacist of Dale Hollow Pharmacy (then known as Donaldson Pharmacy); and Pamela Spivey, 55, co-owner of Xpress Pharmacy (all of Celina...

Paginación

  • Primera página «
  • Anterior
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Page 9
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster